Author:
Bittner Beate,Schmidt Johannes
Reference41 articles.
1. Anti-counterfeit technologies: A pharmaceutical industry perspective;Bansal;Scientia Pharmaceutica,2013
2. Tertiary patenting on drug-device combination products in the United States;Beall;Nature Biotechnology,2018
3. Subcutaneous immunoglobulin replacement in primary immunodeficiencies;Berger;Clinical Immunology,2004
4. Connected drug delivery devices to complement drug treatments: Potential to facilitate disease management in home setting;Bittner;Medical Devices: Evidence and Research,2019
5. Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC);Bittner;Pharmazie,2012